Daesung Microbiological Labs. Co. Ltd

Researches and manufactures veterinary vaccines and medicines for livestock, fish, and canines.

036480 | KO

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: South Korea
Address:: 경기도 의왕시 덕영대로 103, 의왕시
Website:: https://eng.dsmbio.co.kr/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Daesung Microbiological Labs. Co., Ltd. is a veterinary pharmaceutical company engaged in the research, manufacture, and sale of animal medicines. Established in 1968, the company has over half a century of experience contributing to the health of the livestock industry. Its product portfolio includes a wide range of vaccines, antibiotics, and other therapeutic drugs for various animals, including swine, poultry, cattle, canines, and fish. As a leading vaccine manufacturer with KGMP (Korean Good Manufacturing Practice) certification, the company focuses on producing high-quality products aimed at disease prevention and promoting animal welfare.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Daesung Microbiological Labs. Co. Ltd and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Daesung Microbiological Labs. Co. Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Daesung Microbiological Labs. Co. Ltd via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Newbury Pharmaceuticals AB Develops specialty prescription drugs for Scandinavia in oncology, rare diseases & neurology.	Sweden	NEWBRY
New Nordic Healthbrands AB Develops and markets herbal supplements & beauty products for natural wellness consumers globally.	Sweden	NNH
Newron Pharmaceuticals S.p.A. Biopharma developing novel therapies for nervous system diseases like Parkinson's and schizophrenia.	Italy	NWRN
NextCell Pharma AB Develops off-the-shelf cell therapies for autoimmune diseases like type 1 diabetes.	Sweden	NXTCL
NGeneBio Co., Ltd. Provides NGS-based diagnostics, software, and liquid biopsy for precision oncology and healthcare.	South Korea	354200
NIBEC CO., LTD. Biotech CDMO creating regenerative products with peptide and biomaterial technologies.	South Korea	138610
NIPPON CHEMIPHAR CO., LTD. Develops generic drugs, allergy treatments, and novel pharmaceuticals for a global market.	Japan	4539
Nippon Shinyaku Co.,Ltd. Develops pharmaceuticals and functional foods to improve healthcare and wellbeing.	Japan	4516
NKMAX Co., Ltd. Biotech firm for NK cell therapies, global research reagents, diagnostics, and supplements.	South Korea	182400
Novacyt Designs and supplies molecular diagnostic tests and PCR kits for human, veterinary, and food safety.	France	ALNOV